BioML Seminar 1 — Antibody Engineering with Peyton Greenside!
Join us for the kickoff of the BioML seminar in Evans Hall (Rm 60) presented by Machine Learning at Berkeley. We're hosting Peyton Greenside, co-founder of BigHat Biosciences, a company working on antibody engineering.
A pioneer of deep learning applied to life science problems, Peyton has developed computational, statistical, and AI/ML techniques to model, understand, and optimize biological sequences in academia and industry. Peyton was an inaugural Schmidt Science Fellow, a computational biologist at the Broad Institute, a scientific founder of Valis, and holds a PhD from Stanford University (Accel Innovation Scholar), an MPhil in Computational Biology from Cambridge University (Herchel Smith Scholar), and a BA in Applied Math from Harvard.
She founded BigHat Biosciences in 2019, enabling drug developers to create antibodies and complex therapeutics much faster than usually possible.
